ID20291A - SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS - Google Patents
SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERSInfo
- Publication number
- ID20291A ID20291A IDP971607A ID971607A ID20291A ID 20291 A ID20291 A ID 20291A ID P971607 A IDP971607 A ID P971607A ID 971607 A ID971607 A ID 971607A ID 20291 A ID20291 A ID 20291A
- Authority
- ID
- Indonesia
- Prior art keywords
- oxycutiratic
- metaloproteasa
- matriers
- acids
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64838496A | 1996-05-15 | 1996-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID20291A true ID20291A (en) | 1998-11-19 |
Family
ID=24600568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP971607A ID20291A (en) | 1996-05-15 | 1997-05-14 | SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0912487A1 (en) |
| JP (1) | JP3417951B2 (en) |
| CN (1) | CN1163466C (en) |
| AR (1) | AR007096A1 (en) |
| AU (1) | AU727648B2 (en) |
| CA (1) | CA2253869C (en) |
| CO (1) | CO4990925A1 (en) |
| HR (1) | HRP970246B1 (en) |
| ID (1) | ID20291A (en) |
| MY (1) | MY132470A (en) |
| PA (1) | PA8429401A1 (en) |
| PE (1) | PE65998A1 (en) |
| SV (1) | SV1997000034A (en) |
| TN (1) | TNSN97085A1 (en) |
| TW (1) | TW467892B (en) |
| WO (1) | WO1997043238A1 (en) |
| YU (1) | YU18797A (en) |
| ZA (1) | ZA974032B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6288063B1 (en) | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
| GB0321538D0 (en) | 2003-09-13 | 2003-10-15 | Glaxo Group Ltd | Therapeutically useful compounds |
| WO2009022740A1 (en) * | 2007-08-15 | 2009-02-19 | Kyorin Pharmaceutical Co., Ltd. | Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient |
| CN106458938A (en) | 2014-04-03 | 2017-02-22 | 拜耳制药股份公司 | Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof |
| WO2015150363A1 (en) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids and use thereof |
| EP3126358A1 (en) | 2014-04-03 | 2017-02-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5902791A (en) * | 1994-01-22 | 1999-05-11 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
-
1997
- 1997-05-09 ZA ZA9704032A patent/ZA974032B/en unknown
- 1997-05-09 HR HR970246A patent/HRP970246B1/en not_active IP Right Cessation
- 1997-05-09 CO CO97025164A patent/CO4990925A1/en unknown
- 1997-05-09 TN TNTNSN97085A patent/TNSN97085A1/en unknown
- 1997-05-09 MY MYPI97002045A patent/MY132470A/en unknown
- 1997-05-12 PE PE1997000362A patent/PE65998A1/en not_active Application Discontinuation
- 1997-05-12 TW TW086106284A patent/TW467892B/en not_active IP Right Cessation
- 1997-05-12 PA PA19978429401A patent/PA8429401A1/en unknown
- 1997-05-12 AR ARP970101976A patent/AR007096A1/en unknown
- 1997-05-12 EP EP97926454A patent/EP0912487A1/en not_active Withdrawn
- 1997-05-12 WO PCT/US1997/007975 patent/WO1997043238A1/en not_active Application Discontinuation
- 1997-05-12 CA CA002253869A patent/CA2253869C/en not_active Expired - Fee Related
- 1997-05-12 CN CNB971964599A patent/CN1163466C/en not_active Expired - Fee Related
- 1997-05-12 SV SV1997000034A patent/SV1997000034A/en not_active Application Discontinuation
- 1997-05-12 JP JP54100297A patent/JP3417951B2/en not_active Expired - Fee Related
- 1997-05-12 YU YU18797A patent/YU18797A/en unknown
- 1997-05-12 AU AU31219/97A patent/AU727648B2/en not_active Ceased
- 1997-05-14 ID IDP971607A patent/ID20291A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE65998A1 (en) | 1998-10-20 |
| MY132470A (en) | 2007-10-31 |
| EP0912487A1 (en) | 1999-05-06 |
| AR007096A1 (en) | 1999-10-13 |
| AU727648B2 (en) | 2000-12-21 |
| HRP970246B1 (en) | 2002-04-30 |
| CN1225622A (en) | 1999-08-11 |
| AU3121997A (en) | 1997-12-05 |
| CN1163466C (en) | 2004-08-25 |
| ZA974032B (en) | 1998-02-19 |
| PA8429401A1 (en) | 2000-05-24 |
| HRP970246A2 (en) | 1998-04-30 |
| CO4990925A1 (en) | 2000-12-26 |
| SV1997000034A (en) | 1999-07-05 |
| JP3417951B2 (en) | 2003-06-16 |
| TNSN97085A1 (en) | 2005-03-15 |
| TW467892B (en) | 2001-12-11 |
| WO1997043238A1 (en) | 1997-11-20 |
| CA2253869C (en) | 2003-04-22 |
| YU18797A (en) | 1999-11-22 |
| CA2253869A1 (en) | 1997-11-20 |
| JPH11509870A (en) | 1999-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9510256A (en) | Derivatives of 3-aryl-tetronic acid | |
| ID16866A (en) | COMPLEX COMPLEX OF ARYL-HETEROSICLIC SALT INCLUSION | |
| DE69703385D1 (en) | ALCOXYACETIC ACID DERIVATIVES | |
| NO990821D0 (en) | Arylsulfonylamino-hydroxamic acid derivatives | |
| NO307961B1 (en) | Method of Preparation of an Ester | |
| EE200000573A (en) | Substituted indolealkanoic acids | |
| ID19227A (en) | METHOD OF PRODUCING CARBOXIC ACIDS | |
| ATE238984T1 (en) | SULFONYLAMINOCARBOXYLIC ACIDS | |
| EE200000241A (en) | Process for the preparation of 8-methoxyquinolone carboxylic acids | |
| PT829205E (en) | PRODUCTION OF CONDIMENTO | |
| DE69718338T2 (en) | 3-ALKOXYISOXAZOLE-4-YL-SUBSTITUTED 2-AMINOCARBONIC ACID DERIVATIVES | |
| ID22222A (en) | PROCESS OF MAKING SUBSTITUTED TIAZOLIDINADION | |
| ID16838A (en) | COMPOSITION OF DEKAFLUOROPENTANA | |
| ID21901A (en) | PROCESS OF MAKING HYDROXYLAMONIUM SALT | |
| NO20001777L (en) | Process for the preparation of substituted 4-phenyl-4-cyanocyclohexanecarboxylic acids | |
| ID20291A (en) | SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS | |
| ID29253A (en) | PROCESS OF MAKING MULTIDENTAT COMPOUND FOSFIT | |
| ATE222704T1 (en) | PRODUCTION OF FROZEN CONFESSIONALS | |
| ID18300A (en) | METHOD OF PENEMPERAN | |
| DE69707251D1 (en) | Maleimidobenzoic acid ester | |
| ID17419A (en) | COMPOSITION OF DEKAFLUOROPENTANA | |
| ID19799A (en) | PROCESS OF MAKING PAKLITAKSEL | |
| NO980316D0 (en) | Process for the preparation of N-vinylcarprolactam polymerisates | |
| DE69707882D1 (en) | CARBONYLATION PROCEDURE OF PENTENIC ACIDS | |
| IS5077A (en) | Microfinite form of tetrahydropyridine derivative |